← All companies

Biogen

Healthcare & Life Sci

Company overview

Biogen develops medicines for hard-to-treat diseases. Its major drugs include Tecfidera, Avonex, Plegridy, and Tysabri for multiple sclerosis, Spinraza for spinal muscular atrophy, and Skyclarys for Friedreich's ataxia.

Biogen was founded in 1978 in Geneva. It's a public company traded on NASDAQ under the ticker BIIB. In 2025 it reported $9.89 billion in revenue and had 7,500 employees. Historically, the median salary is ~$223,500. Biogen is a top-tier H-1B sponsor.

Industry
Healthcare & Life Sci
Headquarters
Cambridge, United States

Filters

Create your account

Create an account to save jobs and track applications.